3-D Matrix, Ltd. (TYO:7777)

Market Cap	66.55B +388.3%
Revenue (ttm)	8.47B +40.5%
Net Income	5.00M
EPS	0.05
Shares Out	121.21M
PE Ratio	13,309.13
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,909,500
Average Volume	7,124,405
Open	548.00
Previous Close	549.00
Day's Range	538.00 - 575.00
52-Week Range	102.00 - 567.00
Beta	0.34
RSI	75.72
Earnings Date	Mar 13, 2026

About 3-D Matrix

3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 114
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7777

Financial Performance

In fiscal year 2025, 3-D Matrix's revenue was 6.93 billion, an increase of 51.13% compared to the previous year's 4.59 billion. Losses were -2.50 billion, 880.8% more than in 2024.